BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.98 +0.35%

+$0.05 today

Market cap
$352.22M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.15M

Average 0.15M

BWAY Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

BrainsWay Ltd.NASDAQ: BWAY

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development grows, but more slowly than its trailing trend

Q1 FY2026 research & development of $2.88M rose 23.5% year over year, behind the +28.6% change in trailing-twelve-month research & development. Sequentially, it rose 13.8% from the prior quarter. Over 3 fiscal years it compounded at +7.7% a year.

Context

  • Research & development amounted to 18.4% of revenue in FY2025, up 0.9 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +23.5% toward the trailing-twelve-month pace of +28.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$2.88M+13.8% QoQ
Last fiscal yearDec 2025
$9.6M+33.6% YoY
LTMMar 2026
$10.15M+28.6% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+23.5%——
1 year+33.6%——
3-year CAGR+7.7%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
9.6M USD
Year-over-year change
+33.6%
4-year CAGR
+10.7%

Research & Development vs competitors

How BWAY compares with its peers on the latest reported figures

  • BWAY's LTM Mar 2026 research & development of $10.15M is the 2nd highest of the 4 companies compared; the peer median is $6.33M.
  • Its year-over-year change of +28.6% is the highest of 4, against a peer median of -32.8%.
  • Research & development amounts to 18.1% of revenue for BWAY, versus a peer median of 26.8%.
BWAY Competitors Peer median
Research & Development for BWAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NPCENeuroPace, Inc.LTM Mar 2026$27.64M +9.2%+8.3%27.8%
BWAYBrainsWay Ltd.LTM Mar 2026$10.15M +28.6%+7.7%18.1%
STIMNeuronetics, Inc.LTM Mar 2026$6.33M -47.4%-11.0%4.2%
HSDTSolana CompanyLTM Mar 2026$2.57M -32.8%-6.3%26.8%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding BWAY) $6.33M-32.8%-6.3%26.8%

Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue29.66M27.18M31.79M41.02M52.23M
Cost of Revenue6.6M7.13M8.31M10.44M12.84M
Gross Profit23.06M20.05M23.48M30.58M39.39M
Gross Margin77.7%73.8%73.9%74.6%75.4%
Research & Development6.39M7.68M6.67M7.19M9.6M
Selling, General & Admin21.66M25.05M21.64M22M25.46M
Operating Expenses28.06M32.73M28.44M29.19M35.06M
Depreciation & Amortization1.69M1.53M1.34M1.77M1.54M
EBITDA(4.67M)(11.45M)(2.56M)5.36M11.46M
EBITDA Margin-15.8%-42.1%-8.1%13.1%21.9%
Operating Income(5M)(12.68M)(4.96M)1.39M4.32M
Operating Margin-16.9%-46.7%-15.6%3.4%8.3%
Interest Income225K1.11M2.17M2.48M5.64M
Interest Expense141K68K298K1.36M2.23M
Other Income / Expenses(1.42M)(351K)1.01M2.07M3.39M
Income Before Tax(6.42M)(13.03M)(3.95M)3.46M7.71M
Pre-Tax Margin-21.6%-48.0%-12.4%8.4%14.8%
Income Tax Expense43K315K251K538K77K
Net Income(6.46M)(13.35M)(4.2M)2.92M7.63M
Net Margin-21.8%-49.1%-13.2%7.1%14.6%
EPS (Basic)(0.21)(0.43)(0.13)0.090.40
EPS (Diluted)(0.21)(0.43)(0.13)0.090.36
Weighted Avg Shares31.15M32.98M33.16M33.97M19.08M
Weighted Avg Shares (Diluted)31.15M32.98M33.16M34.77M21.21M

BrainsWay Ltd.

NASDAQ:BWAY

Intrinsic Alpha fair value

Locked

Current Price

$8.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.